Onyx is a liquid embolic agent that is injected into an artery to occlude blood flow. In subdural hematoma, it is used to block the MMA, stopping the chronic oozing of blood into the subdural space.
Spark Biomedical, Inc., a leader in wearable neurostimulation, announced today that the Trauma Research and Combat Casualty ...
New analyses indicate factor VIIa could benefit a small group of patients with intracerebral hemorrhage treated very early, ...
Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas: Boston Friday, February 6, 2026, 17:00 Hrs [IST] Balt Inc, a global ...
BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ liquid embolic agent. Squid is ...
New insights into spontaneous coronary artery dissection—a devastating cause of heart attacks in young, healthy patients—were ...